Jiangxi Sanxin Medtec Co.Ltd(300453)
Annual report for 2021
2022011
March 2022
Section I important tips, contents and definitions
The board of directors, the board of supervisors and the directors, supervisors and senior managers of the company guarantee that the contents of the annual report are true, accurate and complete without false records, misleading statements or major omissions, and bear individual and joint legal liabilities.
Peng Yixing, the person in charge of the company, Zou Beiting, the person in charge of accounting, and Shu Nanmei, the person in charge of the accounting organization (Accounting Supervisor), declare that they guarantee the authenticity, accuracy and completeness of the financial report in this annual report.
All directors have attended the meeting of the board of directors to consider this report.
(I) national policy risk
The medical device industry is not only a key industry encouraged and supported by the state, but also an industry with a high degree of national supervision, including industry access, production conditions, quality standards, etc. Major changes in relevant national regulatory policies may lead to new changes in the competition pattern of the whole industry, which will bring new challenges to the production and operation of the company.
(II) quality control risk
The company’s main products are national class III medical devices. Their safety and effectiveness are related to people’s health and life. They are key national supervision and management devices. China has strictly examined the establishment of relevant enterprises and the production and sales qualification of products, and established a systematic management and market access system. Foreign countries also have strict standards for the market access of medical devices. If the company cannot continuously and effectively implement the control systems and measures related to quality management, or the product has quality problems, it will damage the reputation of the company and affect the operation of the company.
(III) management risks caused by business integration and scale expansion
With the development of the company’s M & a business and the development of new business fields, higher requirements are put forward for the company’s management level. The company may face challenges and risks in business integration and improving the overall operation efficiency. The profit distribution plan approved by the board of directors is: take 39402750000 shares as the base, distribute cash dividend of 1.50 yuan (including tax) to all shareholders for every 10 shares, give bonus shares of 0 shares (including tax), and transfer capital reserve to all shareholders for every 10 shares.
catalogue
Section I important tips, contents and definitions Section 2 company profile and main financial indicators 8 section III Management Discussion and Analysis Section IV corporate governance 38 Section V environmental and social responsibility 53 section VI important matters Section VII share changes and shareholders Section VIII preferred shares 71 section IX relevant information of bonds Section x financial report seventy-three
Directory of documents for future reference
1. The financial statements containing the signatures and seals of the legal representative of the company, the person in charge of accounting and the person in charge of accounting organization (Accounting Supervisor). 2. The original of the audit report with the seal of the accounting firm and the signature and seal of the certified public accountant. 3. Originals of all company documents and announcements publicly disclosed during the reporting period. The location of the above documents for future reference: the Securities Investment Department of the company.
interpretation
Explanatory item refers to the explanatory content
Jiangxi Sanxin Medtec Co.Ltd(300453) , the company, the company, the parent company and the issuer refer to Jiangxi Sanxin Medtec Co.Ltd(300453)
Sanxin Co., Ltd. refers to Jiangxi Jiangxi Sanxin Medtec Co.Ltd(300453) Instrument Co., Ltd., whose name was changed to Jiangxi Jiangxi Sanxin Medtec Co.Ltd(300453) Instrument Group Co., Ltd. in 2002, which is the former name of the company
Yunnan Sanxin refers to the wholly-owned subsidiary of the company, Yunnan Jiangxi Sanxin Medtec Co.Ltd(300453) Technology Co., Ltd
Sichuan weilisheng refers to Sichuan weilisheng Medical Technology Co., Ltd., a wholly-owned subsidiary of the company
Jiangxi shengdankang refers to Jiangxi shengdankang Medical Technology Co., Ltd., a wholly-owned subsidiary of the company
Xinweikang refers to Jiangxi xinweikang Trading Co., Ltd., a wholly-owned subsidiary of the company
Ningbo filar refers to the holding subsidiary of the company, Ningbo filar medical supplies Co., Ltd
Heilongjiang xinpinxi refers to the holding subsidiary of the company, Heilongjiang xinpinxi Medical Technology Co., Ltd
Chengdu weilisheng refers to the secondary subsidiary of the company, Chengdu weilisheng Biotechnology Co., Ltd
Ganyi company refers to Jiangxi ganyi Health Industry Investment Co., Ltd., a wholly-owned subsidiary of the company
Chengtukang refers to Jiangxi chengtukang Technology Co., Ltd., a wholly-owned secondary subsidiary of the company
Colvin refers to Jiangxi Colvin Biotechnology Co., Ltd., a wholly-owned secondary subsidiary of the company
CSRC refers to the China Securities Regulatory Commission
Shenzhen stock exchange refers to Shenzhen Stock Exchange
MIIT refers to the Ministry of industry and information technology of the people’s Republic of China
Health commission refers to the health commission of the people’s Republic of China
NDRC refers to the development and Reform Commission of the people’s Republic of China
Company law means the company law of the people’s Republic of China
Securities Law means the securities law of the people’s Republic of China
Stock listing rules refer to the gem stock listing rules of Shenzhen Stock Exchange
Articles of association refers to Jiangxi Sanxin Medtec Co.Ltd(300453) articles of association
The reporting period, the reporting period and the current reporting period refer to 2021, i.e. from January 1, 2021 to December 31, 2021
The end of the reporting period refers to December 31, 2021
The same period of last year refers to 2020, i.e. from January 1, 2020 to December 31, 2020
Yuan and 10000 yuan refer to RMB yuan and 10000 yuan
DEHP refers to a kind of phthalate, which is usually used as plasticizer
TPU refers to thermoplastic polyurethane elastomer, which is a kind of polymer material
PVC means polyvinyl chloride
PC means polycarbonate
PP refers to polypropylene
One of the procedures of medical device registration and review.
In the process of registration review, when the applicant or notes the registration supplement
If the registration data submitted by the registrant for the first time cannot meet the relevant requirements, supplementary data shall be submitted.
Medical devices with low risk and safety and effectiveness can be ensured by routine management shall be designated by class I medical devices in districts
The drug regulatory department of the people’s government at the municipal level shall implement the filing management
Medical devices with moderate risk and requiring strict control to ensure their safety and effectiveness are designated by provincial and class II medical devices
The drug regulatory departments of the people’s governments of autonomous regions and municipalities directly under the central government implement registration administration
With high risk, special measures need to be taken to strictly control and manage to ensure its safety and effectiveness
Medical devices shall be registered and managed by the drug regulatory department under the State Council
Section II Company Profile and main financial indicators
1、 Company information
Stock abbreviation Jiangxi Sanxin Medtec Co.Ltd(300453) stock code Jiangxi Sanxin Medtec Co.Ltd(300453)
Chinese name of the company Jiangxi Sanxin Medtec Co.Ltd(300453)
Chinese abbreviation of the company Jiangxi Sanxin Medtec Co.Ltd(300453)
Foreign name of the company (if any) Jiangxi Sanxin MEDTEC Co., Ltd
Abbreviation of the company’s foreign name (if any) Sanxin MEDTEC
Legal representative of the company: Peng Yixing
Registered address: No. 999, Fushan Avenue, Xiaolan Economic Development Zone, Nanchang County, Jiangxi Province
Postal code of registered address 330200
In December 2010, the registered address of the company was changed from Sanjiang street to No. 999, Fushan Avenue, Xiaolan Economic Development Zone, Nanchang County, Nanchang City, Jiangxi Province
Historical changes of the company’s registered address
In February 2016, the registered address of the company was changed from No. 999, Fushan Avenue, Xiaolan Economic Development Zone, Nanchang County, Nanchang City, Jiangxi Province to No. 999, Fushan Avenue, Xiaolan Economic Development Zone, Nanchang County, Jiangxi Province
Office address: No. 999, Fushan Avenue, Xiaolan Economic Development Zone, Nanchang County, Jiangxi Province
Postal code of office address 330200
Company Internet website http://www.sanxin-med.com./
E-mail sanxinkeji1997163.com.
2、 Contact person and contact information
Secretary of the board of directors and securities affairs representative
Name: Liu Ming, Zhou Wenyan
Contact address: No. 999, Fushan Avenue, Xiaolan Economic Development Zone, Nanchang County, Jiangxi Province
Tel: 079185950380
Fax: 079185950380
E-mail sanxinkeji1997@1
